Leo Pharma starts phase II trial of Korean tablet
224 adults with moderate to severe eczema will test a potential tablet treatment, which Leo Pharma secured the rights to in 2018.
by mikkel aabenhus hemmingsen, translated by catherine brett
Leo Pharma is ready to take the next step with its tablet treatment LEO 152020, which is being tested as a potential treatment for atopic eczema.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
